Skip to content

Omeros OMER Operating Cash Flow

Operating Cash Flow at other companies

Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-$46.05M-6.7%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-$44.3M+9.7%
Immunome logo
ImmunomeIMNM
-$58.64M-10.5%
Vor Biopharma logo
Vor BiopharmaVOR
-$38.25M-23.1%
Annexon logo
AnnexonANNX
-$46.8M+6.5%
Arcus Biosciences logo
Arcus BiosciencesRCUS
-$138M-4.5%

Other financials

Income statement

See full
Revenue$9.9M
Gross profit$29.7M
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$775.86M+313%
P/S8.6×

Profitability

See full
Gross margin98.9%
Operating margin-181.8%
Net margin-136.6%
FCF margin-121.6%

Returns & leverage

See full
Return on equity86.6%
Debt / equity0.3×-1.1×
Current ratio+1.9×

Where this comes from

Reported directly by Omeros in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Omeros’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omeros's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omeros's operating cash flow?
Omeros (OMER) reported operating cash flow of -$14.51M in Q1 2026.
How has Omeros's operating cash flow changed year-over-year?
Omeros's operating cash flow increased by 59.5% year-over-year, from -$35.84M to -$14.51M.
What is the long-term trend for Omeros's operating cash flow?
Over 3 years (2021 to 2025), Omeros's operating cash flow has grown at a 1.9% compound annual growth rate (CAGR), from -$109.72M to -$116.09M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.